Publications and Presentations Database

Sort by: [ Author (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Fasaye, G. - A., Obisesan, T., Cupples, A. L., et al. (2008).  Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genetics in medicine : official journal of the American College of Medical Genetics. 10(3), 207-14. Abstract
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2010).  How does pleiotropic information affect health behavior changes? Initial results from the REVEAL Study, a randomized trial of genetic testing for Alzheimer’s disease.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Cupples, L. A., et al. (2010).  Telephone and in-person disclosure of genetic test results: 6-week recall, comprehension, and distress among participants in the REVEAL Study.
Christensen, K. D., Jayaratne, T. E., Roberts, J. S., Kardia, S. L. R., & Petty, E. M. (2010).  Understandings of basic genetics in the United States: results from a national survey of black and white men and women. Public health genomics. 13(7-8), 467-76. Abstract
Christensen, K. D., Jayaratne, T. E., Roberts, J. S., Kardia, S. L. R., & Petty, E. M. (2009).  Black and White Americans’ Understandings of Genetics.
Chung, W. W., Chen, C. A., Cupples, A. L., Roberts, J. S., Hiraki, S. C., Nair, A. K., et al. (2009).  A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease. Alzheimer disease and associated disorders. 23(1), 50-6. Abstract
Connell, C. M., Roberts, J. S., McLaughlin, S. J., & Carpenter, B. D. (2009).  Black and white adult family members' attitudes toward a dementia diagnosis. Journal of the American geriatrics society. 57(9), 1562-8. Abstract
Connell, C. M., Scott Roberts, J., & McLaughlin, S. J. (2007).  Public opinion about Alzheimer disease among blacks, hispanics, and whites: results from a national survey. Alzheimer disease and associated disorders. 21(3), 232-40. Abstract
Connell, C. M., Roberts, J. S., & McLaughlin, S. J. (2005).  Public knowledge about Alzheimer's disease and attitudes toward risk reduction: Results from a national survey.
Connell, C. M., Roberts, J. S., Janevic, M. R., & Shaw, B. A. (2003).  Racial differences in knowledge and attitudes about Alzheimer’s disease: Implications for educational interventions.
Connell, C. M., Scott Roberts, J., McLaughlin, S. J., & Akinleye, D. (2009).  Racial differences in knowledge and beliefs about Alzheimer disease. Alzheimer disease and associated disorders. 23(2), 110-6. Abstract
E
Eckert, S. L. R., Katzen, H., Roberts, J. S., Barber, M., Ravdin, L. D., Relkin, N. R., et al. (2006).  Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. Genetics in medicine : official journal of the American College of Medical Genetics. 8(12), 746-51. Abstract
F
Fanshawe, T. R., Prevost, T. A., Roberts, J. S., Green, R. C., Armstrong, D., & Marteau, T. M. (2008).  Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates. Genetic testing. 12(3), 381-6. Abstract
G
Goldman, J. S., Hahn, S. E., Catania, J. W., LaRusse-Eckert, S., Butson, M. B., Rumbaugh, M., et al. (2011).  Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in medicine : official journal of the American College of Medical Genetics. 13(6), 597-605. Abstract
Gooding, H. C., Linnenbringer, E. L., Burack, J., Roberts, J. S., Green, R. C., & Biesecker, B. B. (2006).  Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk. Patient education and counseling. 64(1-3), 259-67. Abstract
Gornick, M. C., Ryan, K. A., Roberts, J. S., Stoffel, E., & Zikmund-Fisher, B. J. (2017).  Development of a genomic test results report for oncologists.
Gornick, M. C. (2016).  Cancer patients’ expectations of benefits from genome sequencing are not matched by post-test results: Findings from the MI-ONCOSEQ Study.
Gornick, M. C., Scherer, A. M., Sutton, E. J., Ryan, K. A., Exe, N. L., Li, M., et al. (2017).  Effect of Public Deliberation on Attitudes toward Return of Secondary Results in Genomic Sequencing.. Journal of genetic counseling. 26(1), 122-132. Abstract
Gornick, M. C., Cobain, E., Le, L. Q., Bartnik, N., Stoffel, E., Chinnaiyan, A., et al. (2017).  Oncologists’ use of tumor sequencing findings and patient derived benefit.
Gornick, M. C., Ryan, K. A., Scherer, A. M., Roberts, J. S., De Vries, R. G., & Uhlmann, W. R. (Submitted).  Interpretations of the term "actionable" when discussing genetic test results: What you mean is not what I heard. Journal of Genetic Counseling. Abstract
Gornick, M., Cobain, E., Le, L. Q., Bartnik, N., Stoffel, E., Schuetze, S., et al. (2018).  Oncologists’ use of clinical sequencing data to inform clinical management. JCO Precision Oncology. Abstract
Gornick, M. C. (2016).  MICHR data.
Green, R. C., Roberts, J. S., Brown, T. C., Whitehouse, P. J., Barber, M., Relkin, N. R., et al. (2002).  How many adult children of patients with Alzheimer’s disease will choose genetic susceptibility testing with APOE genotyping?.
Green, R. C., Christensen, K. D., Cupples, A. L., Relkin, N. R., Whitehouse, P. J., Royal, C. D. M., et al. (2014).  A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.. Alzheimer's & dementia. Abstract
Green, R. C., Roberts, J. S., Cupples, A. L., Relkin, N. R., Whitehouse, P. J., Brown, T., et al. (2009).  Disclosure of APOE genotype for risk of Alzheimer's disease. The New England journal of medicine. 361(3), 245-54. Abstract